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Abstract
Background: Proxies are mathematical calculations based on fasting glucose and/or insulin concentrations
developed to allow prediction of insulin sensitivity (IS) and β-cell response. These proxies have not been evaluated
in horses with insulin dysregulation. The first objective of this study was to evaluate how fasting insulin (FI) and
proxies for IS (1/Insulin, reciprocal of the square root of insulin (RISQI) and the quantitative insulin sensitivity check
index (QUICKI)) and β-cell response (the modified insulin-to-glucose ratio (MIRG) and the homeostatic model
assessment of β-cell function (HOMA-β)) were correlated to measures of IS (M index) using the euglycemic
hyperinsulinemic clamp (EHC) in horses with insulin resistance (IR) and normal IS. A second objective was to
evaluate the repeatability of FI and proxies in horses based on sampling on consecutive days. The last objective
was to investigate the most appropriate cut-off value for the proxies and FI.
Results: Thirty-four horses were categorized as IR and 26 as IS based on the M index. The proxies and FI had
coefficients of variation (CVs) ≤ 25.3 % and very good reliability (intraclass correlation coefficients ≥ 0.89). All proxies
and FI were good predictors of the M index (r = 0.76–0.85; P < 0.001). The proxies for IS had a positive linear
relationship with the M index whereas proxies for β-cell response and FI had an inverse relationship with the M
index. Cut-off values to distinguish horses with IR from horses with normal IS based on the M index were
established for all proxies and FI using receiver operating characteristic curves, with sensitivity between 79 % and
91 % and specificity between 85 % and 96 %. The cut-off values to predict IR were < 0.32 (RISQI), < 0.33 (QUICKI)
and > 9.5 µIU/mL for FI.
Conclusions: All proxies and FI provided repeatable estimates of horses’ IS. However, there is no advantage of
using proxies instead of FI to estimate IR in the horse. Due to the heteroscedasticity of the data, proxies and FI in
general are more suitable for epidemiological studies and larger clinical studies than as a diagnostic tool for
measurement of IR in individual horses.
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Background
Insulin dysregulation (ID) in horses is defined as any
combination of fasting hyperinsulinemia, postprandial
hyperinsulinemia or insulin resistance (IR) [1]. Endo-
crinopathic laminitis is associated with ID and it is
therefore important to identify horses and ponies at-
risk in order to prevent the development of clinical
laminitis [2]. Several methods for diagnosing IR in
horses have been established but the majority of them
have been adapted from human medicine [3, 4]. Prox-
ies are mathematical calculations based on fasting
glucose concentration (FG) and/or fasting insulin (FI)
concentrations developed to allow prediction of insu-
lin sensitivity (IS) and β-cell response [4]. In both
humans and horses, proxies correlate well with quan-
titative measurements of IS [5–7]. In a study by Trei-
ber and coworkers [7] the reciprocal of the square
root of insulin (RISQI), the quantitative insulin sensi-
tivity check index (QUICKI), the modified insulin-to-
glucose ratio (MIRG) and the homeostatic model as-
sessment of β-cell function (HOMA-β) correlated well
with either the IS or the acute insulin response to
glucose (AIRg) quantified by the frequently sampled
intravenous glucose tolerance test (FSIGTT). The
comparisons were made in a group of 46 clinically
healthy Thoroughbreds and Arabian horses. However,
the use of proxies in horses has not been validated in
horses with ID. In several species including the horse,
IS and β-cell response are inversely related to each
other [5, 8–10]. In humans, the proxies for IS are
linearly correlated with quantitative measurements for
IS, whereas proxies for β-cell response are inversely
related [5, 6].
Whereas quantitative methods for assessing IS and
β-cell response are expensive, time consuming and
technically difficult to perform, proxies are inexpen-
sive, easy to obtain and suitable for larger epidemio-
logical studies and clinical trials [4]. Several proxies
have been used in equine research [11, 12] but
whether these proxies provide better information
about the patients’ IS or β-cell response compared
to the insulin and glucose concentrations they are
calculated from has not yet been established. Insulin
concentrations are influenced by feeding [13, 14]
and therefore measurement of FI has been recom-
mended to standardize testing [15]. However, use of
FI to diagnose ID has been shown to have poor sen-
sitivity [16]. On the other hand, a recent study con-
cluded that FI had adequate sensitivity and
specificity when using lower cut-off values than pre-
viously suggested [15].
The first objective of this study was to evaluate how FI
and proxies for IS and β-cell response were correlated to
quantitative measures of IS using the euglycemic hyper-
insulinemic clamp (EHC) in a group of horses with
insulin resistance (IR) and normal IS. A second objective
was to evaluate the repeatability of FI and proxies in
horses based on sampling on consecutive days. The last
Fig. 1 Scatterplots of individual horses’ insulin sensitivities (M index) determined by the euglycemic hyperinsulinemic clamp (n = 60) divided into
3 major groups of horses: Warmblood horses (n = 19); Icelandic horses (n = 23) and Pony breeds (n = 18). Horses with normal insulin sensitivity are
marked with blue circles whereas horses with insulin resistance are marked with orange squares
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objective was to investigate the most appropriate cut-off
value for the proxies and FI.
Results
Subject characteristics
Thirty-four horses were categorized as having IR (25
mares and 9 geldings) and 26 as having normal IS
(15 mares and 11 geldings) based on the M index.
The horses’ individual IS divided by group (warm-
blood horses, Icelandic horses and ponies) are shown
in Fig. 1. Age (mean ± SD) was similar between the 3
groups of horses, P = 0.65 (13.2 ± 4.4, 12.5 ± 5.2 and
11.7 ± 4.8 years for the warmblood horses, Icelandic
horses and pony breeds respectively). The groups of
warmblood horses, Icelandic horses and pony breeds
with IR had mean M indices of 1.8 ± 0.3, 1.3 ± 0.4 and
1.4 ± 0.5 respectively, with no differences between
groups (P > 0.22). The corresponding means for the
M indices of the IS horses within the same groups of
horses were 3.6 ± 1.0, 3.7 ± 0.7 and 3.4 ± 1.0 respect-
ively, with no differences between groups (P > 0.9).
Correlation between proxies and insulin sensitivity
measures from the EHC
Scatter plots showing the correlation between fasting
indices for β-cell response (FI, MIRG and HOMA-β)
and the M index demonstrate an inverse relationship
(Fig. 2, a - c). When IS decreased, the β-cell response
expressed as the FI, MIRG or HOMA-β increased.
The fasting indices for β-cell response were highly
correlated with the M index derived from the EHC;
r = 0.85, 0.76 and 0.84 for FI, MIRG and HOMA-β re-
spectively (P < 0.001). A rectangular hyperbolic rela-
tionship was not evident for any relationship since β
(95 % CI) did not include − 1 for any of the compari-
sons; -1.57 (-1.82 to -1.32), -0.75 (-0.92 to -0.59) and
− 1.25 (-1.46 to -1.03) for FI, MIRG and HOMA-β
respectively.
Scatter plots showed linear correlation between proxies
for IS (1/insulin, RISQI and QUICKI) and the M index
(Fig. 2, d – f). Visual inspection of scatterplots for 1/insu-
lin and RISQI (Fig. 2, d and e) show heteroscedasticity.
The proxies for IS were highly correlated with the M
index derived from the EHC; r = 0.80, 0.82 and 0.82 for 1/
insulin, RISQI and QUICKI respectively (P < 0.001).
Bland‐altman plots, within‐subject variability and
reliability
Bland-Altman plots for proxies and FI are presented in
Fig. 3. All data are presented in relative difference Bland-
Altman plots to correct for increasing measurement error
proportional to the mean (heteroscedasticity). The 95 %
CI for the mean of the difference between study days did
Fig. 2 Scatterplots of individual horse data (n = 60) showing the relationship between fasting indices for β-cell response: FI, fasting insulin
concentration (a); MIRG, modified insulin-to-glucose ratio (b) and HOMA-β, homeostatic model assessment of β-cell function (c) versus the whole
body glucose disposal rate (M index) as well as the relationship between proxies for insulin sensitivity: 1/insulin (d); RISQI, reciprocal of the square
root of insulin (e) and QUICKI, quantitative insulin sensitivity check index (f) versus M index. The line in a – c represents the regression line for log
transformed data (Ln (y) = constant + β  Ln (x)), whereas the line in d – f represents the regression line for weighted linear regression. Orange
squares represent warmblood horses, blue triangles represent Icelandic horses whereas green circles represent pony breeds
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include 0 for tested proxies except for MIRG, although
the 95 % upper CI for MIRG was very close to 0 (-0.9),
suggesting a relatively small effect (bias) of the day of
study.
Within subject variability between days was calculated
and the CVs for fasting indices are presented in Table 1.
The proxies RISQI and QUICKI showed low within-
subject variability (CV of ≤ 12.2 %). The fasting indices
for β-cell response (FI, MIRG, HOMA-β) demonstrated
higher within-subject variability (CV between 17.5 and
25.3 %). The ICC (reliability) for fasting indices are pre-
sented in Table 1. All proxies and FI showed excellent
ICCs (≥ 0.89). There was a significant difference in
MIRG between day 1 and day 2 (P = 0.03).
Cut‐off values for proxies to predict insulin resistance
ROC curves for proxies and FI are presented in Fig. 4.
The ROC curve analysis resulted in an optimal cut-off
value for FI of > 9.5 µIU/mL to predict IR based on the
Mercodia Equine insulin ELISA. This cut-off value
was based on the Youden’s index for maximizing
Fig. 3 Relative difference Bland-Altman plots where test and retest values are divided by their means and expressed as percentage are plotted against
their means for fasting indices for β-cell response: FI, fasting insulin concentration (a); MIRG, modified insulin-to-glucose ratio (b); HOMA-β, homeostatic
model assessment of β-cell function (c) and for insulin sensitivity: 1/insulin (d); RISQI, reciprocal of the square root of insulin (e); QUICKI, quantitative insulin
sensitivity check index (f). The blue dotted line represents limits of agreement and the dashed red line represents the bias for repeated measures
Table 1 Repeatability and reliability for fasting indices obtained from insulin and glucose concentrations measured on two
consecutive days in 60 horses
Variable Day 1 Median (IQR) Day 2 Median (IQR) CV% (CI) ICC CR% Paired t-test (between-test days) P value
Insulin sensitivity:
1/insulin (mL/µIU) 0.088 (0.032–0.22) 0.076 (0.032–0.17) 23.8 (19.2–27.7) 0.95 65 0.10
RISQI ([µIU/mL]−0.5) 0.30 (0.18–0.47) 0.28 (0.18–0.41) 12.2 (9.7–14.2) 0.95 33 0.14
QUICKI 0.33 (0.28–0.39) 0.32 (0.28–0.37) 3.9 (2.9–4.6) 0.94 10 0.06
β-cell response:
FI (µIU/mL) 11.4 (4.7–31.9) 13.2 (6.0–31.5) 23.8 (19.2–27.7) 0.95 65 0.11
MIRG ([µIU]2 /[10mLmg) 4.9 (3.1–8.5) 13.2 (6.0–8.8) 17.5 (13.0–21.1) 0.89 47 0.03
HOMA-β 126 (75–306) 125 (81–257) 25.3 (21.3–28.7) 0.91 70 0.26
RISQI reciprocal of the square root of insulin; QUICKI quantitative insulin sensitivity check index; FI fasting insulin concentration; MIRG modified insulin-to-glucose
ration; HOMA-β homeostatic model assessment of β-cell function; IQR interquartile range; CV coefficient of variation; ICC intraclass correlation coefficient;
CR coefficient of repeatability
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sensitivity and specificity in the investigated popula-
tion, with sensitivity and specificity of 91 % and 85 %
respectively. The cut-off values to distinguish horses
with IR from horses with IS using the proxies MIRG,
HOMA-β, 1/insulin, RISQI and QUICKI are reported
in Table 2. Due to the non-linear inverse relationship
between β-cell response and IS, values higher than
the cut-offs indicate IR for indices estimating the β-
cell response (FI, MIRG, HOMA-β) whereas lower
values than the cut-offs indicate IR for proxies esti-
mating IS (1/insulin, RISQI, QUICKI). The sensitivity
for these fasting indices ranged between 79 % and
91 %, whereas the specificity ranged between 85 % and
96 % in the studied population (Table 2).
Fig. 4 ROC curves for fasting indices for β-cell response: FI, fasting insulin concentration (a); MIRG, modified insulin-to-glucose ratio (b); HOMA-β,
homeostatic model assessment of β-cell function (c) and for insulin sensitivity: 1/insulin (d); RISQI, reciprocal of the square root of insulin (e); QUICKI,
quantitative insulin sensitivity check index (f) using the M index from the euglycemic hyperinsulinemic clamp as the reference. The red dotted diagonal
line represents a completely uninformative test, wherein the area under the curve (AUC) is 50%. The area under the ROC curve with confidence interval
(CI), represented by the thicker line, is reported in each graph. The P value is reported for the test of the null hypothesis that the AUC equals 0.50
Table 2 Calculated cut-off values for fasting indices based on receiver operating characteristic curve and Youden’s index analyses
using the euglycemic hyperinsulinemic clamp (M index) as the reference for diagnosing insulin resistance
Variable Cut-off values to predict IR AUC Sn% (95% CI) Sp% (95% CI
Insulin sensitivity:
1/Insulin (mL/µIU) < 0.11 0.94 (0.88–0.99) 91 (77–97) 85 (66–94)
RISQI ([µIU/ml]−0.5) < 0.32 0.94 (0.88–0.99) 91 (77–97) 85 (66–94)
QUICKI < 0.33 0.93 (0.87–0.99) 85 (70–94) 85 (67–94)
β-cell response:
FI (µIU/mL) > 9.5 0.94 (0.88–0.99) 91 (77–97) 85 (66–94)
MIRG ([µIUins]
2 /[10•L• mggluc]) > 4.4 0.93 (0.87–0.99) 88 (73–95) 85 (66–93)
HOMA-β > 147 0.94 (0.88–0.99) 79 (63–90) 96 (81–100)
RISQI reciprocal of the square root of insulin; QUICKI quantitative insulin sensitivity check index; FI fasting insulin concentration; MIRG modified insulin-to-glucose
ration; HOMA-β homeostatic model assessment of β-cell function; AUC area under the curve; Sn sensitivity; Sp specificity; CI confidence interval
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Discussion
The present study demonstrated that all investigated
proxies and FI were strongly correlated with quantita-
tive measures of the horses’ IS using the M index of
the EHC. However, these correlations had 2 major
types of structure; curvilinear and linear. There was a
curvilinear inverse relationship between fasting indices
for the β-cell response (FI, MIRG or HOMA-β) and
the M index whereas the relationship was linear be-
tween proxies for IS (1/insulin, RISQI or QUICKI)
and the M index. We observed that proxies and FI in
general demonstrated reasonably good repeatability
and very high reliability. Cut-off values to predict IR
were established for all proxies and FI using ROC
curve analyses to maximize sensitivity and specificity.
The sensitivity for these fasting indices in the investi-
gated population ranged between 79 and 91 % and
the specificity ranged between 85 and 96 %.
Kahn and coworkers [5] have reported a non-linear in-
verse relationship between FI and IS in humans. A
hyperbolic relationship has been reported between the
β-cell response and IS in several species including the
horse [5, 8, 17, 18]. A curvilinear inverse relationship
was also found between FI and IS determined by the
EHC in this study, but it was not found to be hyperbolic.
Fasting insulin concentrations are thus an estimate of β-
cell response for the steady state period during the post
absorptive phase but the estimate is different than those
obtained from studies in which secretion is stimulated
by exogenous glucose e.g. oral glucose tolerance tests,
hyperglycemic clamp and FSIGTT [17, 19]. During basal
(fasting) steady-state condition, glucose concentration is
dependent on insulin-regulated hepatic glucose produc-
tion and glucose removal by tissues, whereas insulin
concentration is dependent on the β-cell response to
glucose originating from the liver and insulin removal
[4]. Increased FI therefore reflect both hepatic IR, in-
creased insulin secretion as well as metabolic clearance
of insulin. Notably, FI do not take into account the effect
of decreased functional β-cell mass. Fasting insulin con-
centrations thus give erroneous estimates for β-cell func-
tion in patients with diabetes mellitus type 2 [4]. In the
horse with ID, hyperinsulinemia is the typical manifest-
ation [1] and not diabetes mellitus type 2, suggesting
that FI can be used for diagnosing ID without a correc-
tion factor using FG. In humans, the HOMA model is
used to estimate β-cell function from FI and FG. The
feedback loop between endogenous glucose production
in the liver and the β-cell response of insulin secretion is
central to the model. The HOMA-β evaluates the β-cell
function by calculating the ratio of FI to FG after nu-
meric adjustment of the values with specific constants
[20]. In a previous study, HOMA-β as well as MIRG
were found to correlate well to the AIRg during an
FSIGTT, a measure of the early insulin response to
intravenous glucose [7]. In fact, these two proxies for β-
cell response gave similar results in terms of specificity,
sensitivity and total predictive power. However, one
problem with MIRG is that horses with hypersinuline-
mia > 50 µIU/mL have erroneously low MIRG values.
This is likely the reason for the lower non-linear correl-
ation to IS for MIRG compared to FI or HOMA-β in the
present study. When values > 50 µIU/mL were excluded
(n = 5) from the analysis the correlation coefficient (r)
increased from 0.76 to 0.82. Thus, the formula for MIRG
is only valid for horses with FI ≤ 50 µIU/mL, which
limits its use in horse populations with ID. An alterna-
tive to MIRG has been suggested by using an adapted
MIRG for ponies (modified insulin-to-glucose ratio for
ponies; MIGRP) [11]. When the adjusted MIRG proxy
was adapted to all our data, MIGRP correlated well to
the M index (Ln(y) = 1,7–1.3  Ln(x); r = 0.82, P < 0.001;
scatterplot data not shown) and yielded a scatterplot
pattern very similar to that of FI versus M index or
HOMA-β versus M index. The fasting indices for β-cell
response in this study, FI, MIRG and HOMA-β, had a
curvilinear inverse relationship with IS and they can
therefore be used not only to estimate the β-cell re-
sponse but also the IS. The simplest index FI had the
best non-linear inverse correlation with the M index. In
this study, we did not quantify the β-cell function, and
we can therefore not draw specific conclusions on how
well FI, MIRG and HOMA-β are able to estimate the β-
cell response in the horse. This is a limitation with the
study since it would have been valuable not only to com-
pare fasting indices with quantitative measures of IS but
also with different aspects of the β-cell response using,
for example, the hyperglycemic clamp [19]. However,
this would have complicated the study and it was not
feasible since we used clinical cases in our study.
Due to the non-linear inverse relationship between FI
and IS in patients with preserved β-cell function, math-
ematical transformation of FI into 1/insulin provides an
estimate of IS. This proxy demonstrated a very good
positive linear correlation with the M index from the
EHC in the present study but data showed heteroscedas-
ticity. Further mathematical transformation by taking
the square root of the denominator (RISQI) improved
the heteroscedasticity to a certain extent but it had a
marginal effect in improving the correlation. In humans,
QUICKI was developed by Katz and coworkers [6] to
obtain a proxy that could be used in both diabetic and
non-diabetic subjects. By log transformation to both FI
and FG in the denominator a correction for patients
with diabetes mellitus type 2, where glucose is high and
insulin is low, was established. As FI has a skewed distri-
bution, log transformation of insulin in the mathematical
formula of QUICKI improved the linear correlation with
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the M index of the EHC with decreased heteroscedasti-
city in the present study compared to the proxy 1/insu-
lin. Similar results with minimal heteroscedasticity and
very good correlation with the M index have been found
for man [6]. If the QUICKI proxy is applicable to equine
patients with diabetes mellitus type 2 has, however, not
been evaluated.
The fasting indices for β-cell response had CV values
between 17.5 % and 25.3 % and ICCs ≥ 0.89. These re-
sults are comparable with the results of repeatability for
peak insulin concentration and AUC for insulin from
the oral sugar test in a previous study (mean CV of
18.3 % and 16.9 % respectively and ICC of 0.83 and 0.91
respectively) [21]. However, the data for CV are not dir-
ectly comparable since the aforementioned study used
mean CVs with a bias with lower values [22]. In com-
parison, dynamic tests that more specifically measure
the β-cell response such as the FSIGTT (AIRg) [23] and
the hyperglycemic clamp (AUC for insulin) [19] demon-
strate much lower CVs and somewhat higher ICC (≤
11.7 % with ICC ≥ 0.93). In contrast, proxies for IS dem-
onstrated lower CVs than the fasting indices for β-cell
response. In comparison with a previous study [24] the
indices FI, RISQI and MIRG in the present study had
better CVs. One explanation is that sampling in this
study was performed early in the morning just before
feeding, which gave standardized basal (fasting) condi-
tions. In the aforementioned study, sampling was done
at 12 AM and hay was available for horses before sam-
pling [24], which may have affected the variability in test
results. The CR is an index that quantifies the repeat-
ability [25]. The relative differences between test and re-
test values and their means were used in order to obtain
normal distribution, and the CR was therefore expressed
in percentage. Since the percentage error was distributed
normally, a 95 % confidence interval could be calculated
around a measurement. The CR is thus the smallest dif-
ference in percentage between two measurements that
can be interpreted as a real difference and not measure-
ment error [25]. Only QUICKI demonstrated a low CR
(10 %). The other fasting indices had much higher rela-
tive CR (30–70 %).
Previous studies have demonstrated poor sensitivity of
FI to diagnose ID [16, 26]. However, the sensitivity and
specificity of a test in a population is affected by the cut-
off value used. In general, reducing the cut-off value im-
proves the sensitivity but decreases the specificity. In a
recent study, the authors demonstrated that the poor
sensitivity for FI was related to the cut-off value used ra-
ther than FI being an intrinsically inappropriate test
[15]. By reducing the commonly suggested cut-off value
of 20 µIU/mL to 5.2 µIU/mL for FI, the sensitivity for
the diagnosis of ID increased from 15 to 63 % without a
major impact on the specificity, which decreased from
100 to 87 % [15]. In comparison, the cut-off value for FI
in the present study was 9.5 µIU/mL with sensitivity of
91 % and specificity of 85 %. The higher cut-off value in
the present study can be explained by the use of differ-
ent techniques for analyses of insulin in the two studies.
The chemiluminescent assay has found to give lower
readings for endogenous equine insulin compared to the
species optimized equine ELISA used in the present
study [27]. The higher sensitivity for FI in the present
study may reflect the study population with an evenly
distributed wide range of IS with relatively fewer sam-
pling points around the cut-off level for FI compared
with the study by Olley and coworkers [15]. Compared
to FI, the proxies gave similar results for predicting IR
with sensitivities of 79 to 91 % and specificities varying
between 85 to 96 %. It has been suggested that blood
samples for insulin concentrations should be obtained
after feeding and not in the morning after feed with-
drawal overnight in order to increase the sensitivity of
the test [28]. However, the postprandial insulin response
after feeding different types of forage vary in magnitude
and duration leading to variable insulin results [13, 14].
The horses in this study were sampled for glucose and
insulin in the morning at 7 AM before feeding to estab-
lish stable basal conditions. This is not always possible
in clinical practice and further research is needed to de-
termine the ideal period of feed withdrawal after the
morning feed for sampling of insulin and glucose later
during the day.
Conclusions
Proxies are mathematical calculations based on FI or the
combination of FI and FG with the following principles
for adjustment in horses with preserved β-cell function.
When FI appears in the numerator of the calculation the
proxy predicts the β-cell response whereas, if FI appears
in the denominator, the proxy predicts IS. This is based
on the curvilinear inverse relationship between insulin
sensitivity and the β-cell response. Thus, proxies will in
fact be able to predict IS regardless of whether they are
intended to estimate the β-cell response or the IS. We
have shown that in a population of horses with a broad
range of IS, no proxy was superior to the others or to FI.
However, the QUICKI showed an additional advantage
compared to the other proxies by offering lower CVs
and CRs. In addition, MIRG is not recommended for
use in ID horses due to limitations with the mathemat-
ical formulae. Thus, there is no advantage in using prox-
ies instead of FI to estimate IR in horses with preserved
β-cell function. Due to the heteroscedasticity of the data,
proxies and FI in general are more suitable for epi-
demiological studies and larger clinical studies than as a
diagnostic tool for measurement of IR in individual
horses. Finally, it is important to point out that the cut-
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off values for FI and proxies presented in this paper are
only valid for analyses based on the Mercodia’s species
optimized equine ELISA since different insulin assays
give different results for equine insulin.
Methods
Horses
All horse owners provided informed written consent.
Thirty-five client owned horses and ponies previ-
ously diagnosed with ID by referring veterinarians
using an oral sugar test [21] were enrolled in the
study. The diagnosis of ID was based on blood sam-
ples obtained between 60 and 90 minutes after oral
administration of the syrup and analyzed for insulin
(Mercodia equine insulin ELISA, Mercodia AB, Upp-
sala, Sweden). To be eligible to participate in the
study the insulin concentration had to be > 90 µIU/
mL (insulin concentrations > 45 µIU/mL is consid-
ered diagnostic for ID). In addition, 26 clinically
healthy horses and ponies owned by the Swedish
University of Agricultural Sciences were included in
the study. The horses were divided into 3 major
groups: warmblood horses (warmbloods and Stan-
dardbreds), Icelandic horses and ponies (pony cross-
breds, Welsh ponies, Gotland ponies and Shetland
ponies). Criteria for inclusion were no ongoing epi-
sode of laminitis based on clinical examination and
normal plasma ACTH adjusted for the season. All
horses in the study were fed a hay or haylage diet
supplemented with minerals. Horses were housed in
individual box stalls and allowed daily turnout in a
dirt or sand paddock. None of the horses had been
on grass pasture for at least 2 months before testing.
Experimental design
All horses were acclimatized for at least 48 hours to
the environment where sampling was to take place.
After acclimatization, horses were sampled for FI and
FG at 7 AM on two consecutive days immediately
followed by an EHC the second day. Blood sampling
for FI and FG as well as the EHC took place after
feed withdrawal overnight.
Proxy measurements
The day before testing an IV catheter (Intranule,
2.0 × 105 mm. Vygon, Ecouen, France) for blood sam-
pling was inserted into one of the jugular veins under
local anesthesia (EMLA, AstraZeneca AB, Södertälje,
Sweden). Blood samples for FI and FG were collected
from the jugular catheter at 7 AM on two consecu-
tive days. Fasting insulin and glucose concentrations
were used to calculate proxies. Insulin sensitivity was
estimated using the proxies 1/Insulin [4], RISQI [7]
and QUICKI [6] whereas the β-cell response was
estimated using FI and the proxies MIRG [7] and
HOMA-β [20].
Proxies were calculated using the following formulae:





QUICKI ¼ 1=ðlog½Insulin þ log½GlucoseÞ
MIRG ¼ ð800 ‒ 0:3
 ð½Insulin ‒ 50Þ2Þ=ð½Glucose ‒ 30Þ
HOMA β ¼ ð20  ½InsulinÞ=ð½Glucose – 3:5Þ
Glucose concentrations expressed in the SI-unit
mmol/L were used for HOMA-β but were converted
into mg/dl before insertion into the formulae for
QUICKI and MIRG. Insulin concentration in µIU/mL
were used in all calculations.
EHC – euglycemic hyperinsulinemic clamp
A second IV catheter (Intranule, 2.0 × 105 mm. Vygon,
Ecouen, France) for infusions was inserted under local
anesthesia (EMLA, AstraZeneca AB, Södertälje, Sweden)
into the contralateral jugular vein in the afternoon on
the day preceding the EHC. Blood samples for determin-
ation of FI and FG were drawn from the sampling IV
catheter immediately before the start of the EHC at 7
AM. The EHC procedure has previously been described
for use in horses [23, 29]. A continuous rate infusion of
regular insulin (Humulin Regular, Eli Lilly Sweden AB,
Solna, Sweden) was maintained throughout the 180 min
clamp procedure at 3 mIU/kg/min. Blood glucose was
kept at 5 mmol/L using a variable continuous rate infu-
sion of glucose (Glucose Fresenius Kabi 500 mg/ml, Fre-
senius Kabi AB, Uppsala, Sweden). Adjustment of the
glucose infusion was made based on the results of meas-
urement (Accu-Check Aviva, Roche Diagnostics Scandi-
navia AB, Bromma, Sweden) of blood glucose
concentration performed every 5 minutes. Serial blood
samples were obtained every 10 minutes during the
clamp for later analyses of plasma glucose to enable cal-
culation of whole body glucose uptake, i.e. metabolic
rate of glucose (M index). The steady-state period of the
clamp was defined as the last 60 minutes. The M index
was defined as the infusion rate of exogenous glucose
administered during the steady state after correction of
the glucose space [23, 29]. Horses were classified as IR if
their M index was < 2.4 mg/kg/min. This cut-off level
was based on the normal distribution of the M index
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(mean and 95 % confidence interval; 3.8 (2.4–5.2) in a
group of metabolically healthy control horses (Icelandic
horses and Gotland ponies) from a previous study [30].
The lower confidence interval for the M index in this
group of horses was used as the cut-off for IR in the
present study.
Analysis of blood samples
All blood samples were collected into evacuated tubes
(Vacuette 9 ml, Greiner Bio-One GmbH, Kremsmünster,
Austria) containing lithium heparin and immediately
placed on ice for 5 minutes before centrifugation (10
min, 2700 × g). Plasma was separated, frozen rapidly and
stored at -80°C until later analysis of plasma insulin and
glucose concentrations. Plasma glucose concentrations
were measured enzymatically with an automated clinical
chemistry analyser (YSI 2300 Stat Plus Analyzer, YSI In-
corporated, Yellow Spring, Ohio). Endogenous concen-
tration of plasma insulin was measured using a
commercialised equine-optimised ELISA (Mercodia
equine insulin ELISA, Mercodia AB, Uppsala, Sweden)
and insulin concentrations were verified with a commer-
cial kit (Mercodia animal insulin control; low, medium
and high, Mercodia AB, Uppsala, Sweden) [31]. All ana-
lyses were performed in duplicate.
Statistical analysis
All data were analyzed using a commercially available
software program (JMP® Pro, version 15.0.0, SAS Insti-
tute Inc, Cary, North Carolina). The age of the horses
and their M index were compared between groups of
horses using one-way ANOVA. Comparisons between
groups were performed by use of the Tukey-Kramer post
hoc test. Variables were tested for homogeneity of vari-
ance using the Levene’s test. All residuals were analyzed
for normality using the Shapiro-Wilk test. Data are pre-
sented as mean ± standard deviation (SD).
According to Bergman’s hypothesis insulin secretion is
inversely related to IS in a rectangular hyperbolic rela-
tionship; y = constant  1/x, where y and x represent β-
cell response and IS respectively [5, 9]. This equation
can be re-expressed through a log-transformation to a
linear model: Ln (y) = constant + β  Ln (x), where β is
the regression coefficient. If β was close to -1 (if the
95 % CI for β included − 1 but excluded 0) the rectangu-
lar hyperbolic relationship was considered to be fulfilled.
This linear function was used to describe the relation-
ship between fasting indices for β-cell response (FI,
MIRG and HOMA-β) and IS (M index).
The proxies for IS (1/Insulin, RISQI and QUICKI)
were initially compared with quantitative measurement
of IS (M index) as an independent variable using simple
linear regression. The residuals were normally distrib-
uted but showed heteroscedasticity and the regression
model was therefore changed to weighted linear
regression.
Bland-Altman plots of absolute differences between
test and retest values against their mean were initially
used to assess for systematic bias and uniform data dis-
tribution. The absolute difference plots demonstrated
heteroscedasticity and data were therefore presented in
relative difference Bland-Altman plots where the differ-
ence between test and retest values were divided by their
means, expressed as percentage, and then plotted against
their mean [32]. The relative differences between test
and retest values were assessed for normal distribution
using the Shapiro-Wilk test. The 95 % CI for the mean
relative differences between test and retest values was
calculated. If the 95 % CI included 0, no systematic bias
was evident. Coefficient of repeatability (CR) was calcu-
lated from the SD of the relative differences (absolute
value of 1.96  SD) and expressed as percentage [25].
The CVs were calculated using the root mean square
method and reported with 95 % confidence interval [22].
The intra-class correlation coefficient (ICC) was com-
puted for all fasting indices using a one-way random ef-
fects model ANOVA on log transformed data to ensure
normal distribution among residual. Comparison be-
tween fasting indices sampled at day 1 and day 2 were
performed using a paired t-test on log transformed data
to ensure normal distribution among all data. Values of
P < 0.05 were considered as significant for all analyses.
Receiver operating characteristic (ROC) curve and
Youden’s index analysis were used to determine the op-
timal cut-off for all proxies and FI with M index as the
reference. Sensitivity, specificity and area under the
curve (AUC) were calculated for each ROC curve ana-
lysis and reported with a 95 % CI.
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